IntroductionParry-Romberg syndrome (PRS) is characterized by progressive dystrophy or loss of subcutaneous tissue in one half of the face, usually beginning in childhood and often continuing with skin changes1. This atrophy affects the subcutaneous tissue, fat, muscle and bone-cartilaginous structures and creates a sunken appearance in the face2. This syndrome is often associated with linear scleroderma and is also known as En coup de sabre 3. The clinical feature of PRS that makes it possible to diagnose is unilateral idiopathic facial atrophy4. This disease is self-limiting and its treatment is multidisciplinary5. Treatment is usually based on the replacement of adipose tissue that has been lost due to atrophy 6. Surgical treatment for PRS often requires a multispecialty approach with repeated procedures, depending on the extent of involvement7. The goal of surgical treatment for PRS patients is to minimize the psychosocial effects and correct the appearance and function of the involved facial structures5.
